is the second most common primary hepatic malignancy, and is associated with high morbidity and mortality. We previously reported the decreased expression of WWOX in EHCC samples, but the underlying mechanism remained unclear. Methods: Immunoprecipitation and immunofluorescence were performed to examine the interaction of WWOX and P38 MAPK. Western blot was carried out to detect the expression of ATF2 and eIF-4E. MTT, colony formation, and Annexin V-FITC assays were performed to detect the cell proliferation and apoptosis. IHC was performed to detect the protein expression in clinical samples. Results: WWOX interacted with P38 and modulated its sub-cellular localization, leading to the cytoplasmic retention of P38. WWOX over-expression inhibited the phosphorylation of ATF2 and eIF-4E, while exogenous P38 reversed this reduction in phosphorylation. Ectopic expression of WWOX in EHCC cells led to inhibited proliferation and stimulated apoptosis in a P38 MAPK-dependent manner. In addition, we found a negative association of WWOX with nuclear localization of P38 and expression of phosphorylated ATF2 in EHCC samples. Conclusion: Our data demonstrated the role of WWOX in EHCC progression, revealing the potential of WWOX/p-ATF2 as a novel diagnostic and prognostic marker, and therapeutic target for EHCC.
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were cultured in DMEM [Invitrogen, CA, USA] supplemented with 10% FBS. All cells were maintained in a humidified atmosphere with 5% CO 2 at 37 °C.
Plasmids
The P38 plasmid was obtained from ADDGENE. The plasmid containing a mutated variant of P38 was generated using a QuikChange® Multi Site-Directed Mutagenesis Kit [Stratagene, USA]. The mutant plasmid encoded the P38 gene containing a "PPAY" to "LLVL" mutation at the amino acid 242. To generate the WW OX plasmid, WWOX cDNA was amplified by PCR and inserted into the pCMV-HA vector [Promega, Madison, WI, USA] using Kpn I and Xho I. The plasmid containing a mutant WWOX was similarly generated using PCR. This mutant contained a deletion of the first WWOX domain.
Immunohistochemistry
With the approval of the Ethics Committee of Changhai Hospital, thirty extrahepatic cholangiocarcinoma and five normal bile duct samples [acquired between [2008] [2009] [2010] [2011] [2012] [2013] were obtained from the paraffin archives of our hospital, For immunohistochemical analysis, endogenous peroxidase activity was blocked using 3% H 2 O 2 for 2 hours, followed by incubation with 5% normal goat serum and then primary antibody overnight at 4°C. Immunohistochemistry was scored by three investigators according to the following scale: 1, negative; 2, minimal; 3, moderate; 4, strong; or 5, maximal. The correlation between WWOX and nuclear P38/p-ATF2 was calculated using the analysis of variance test.
Antibodies and Western blot
For Western blot analysis, cell lysates were separated using 12% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and probed with various antibodies. Primary antibodies included: anti-p-P38 [ 
Immunoprecipitation
For coimmunoprecipitation of WWOX and P38, HEK293 cells were transfected with wild or mutant type of Flag-WWOX and HA-P38 plasmids. After 24 h, cells were harvested in ice-cold lysis buffer [10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 5 mM Na3VO4, 1 mM NaF, and 1 mM phenylmethylsulfonyl fluoride]. After centrifugation, the supernatants were incubated with anti-Flag or anti-HA antibodies at 4°C overnight. After extensive washing with lysis buffer, immunoprecipitates were analyzed by immunoblot as described above using anti-HA or anti-Flag antibodies.
Immunofluorescence
Cells were plated on special 60-mm dishes for con-focal microscopy and treated as described. The cells were then washed with phosphate-buffered saline [PBS] and fixed with 4% paraformaldehyde and 0.25% Triton X-100 for 1 h at room temperature. After blocking for 30 min at room temperature, the cells were incubated with anti-P38 or anti-WWOX antibodies for 1 h at room temperature. The samples were then incubated with corresponding fluorescein isothiocyanate [FITC]-conjugated or Cy3-conjugated secondary antibodies for 1 h at room temperature. The nuclei were stained with 4',6-diamidino-2-phenylindole [DAPI] for 5 min at room temperature. Images were captured using a Leica laser scanning confocal microscope. with a 22-gauge needle to disperse the cell clumps, and then counted on a hemocytometer using trypan blue. The cells were then plated at limiting dilutions in six-well plates and allowed to adhere overnight. The cultures were incubated for 14 days, harvested, and stained with 0.5% crystal violet in methanol. Colony number was determined using a dissecting microscope, with a population of more than 20 cells being counted as one colony.
Annexin V-FITC apoptosis assay
To quantify apoptotic and necrotic cell death induced by over-expression of WWOX or WWOX plus P38, we used the Annexin V-FITC apoptosis detection kit [BD Biosciences], according to the manufacturer's instructions. Briefly, cells in addition with the culture medium were harvested by centrifugation at 1000 rpm for 5 min. After washing with PBS, the cells were stained with annexin V-FITC staining solution for 30 min at room temperature, followed by staining with PI for 10 min at room temperature.
Statistics
Statistical analyses were performed using two-sample, two-tailed, equal variance Student's t-test. Statistical significance was set at *P<0.05 and **P<0.01.
Results

WWOX interactes via its WW1 domain with the P-P-X-Y motif of P38 MAPK
In our previous study, we found that WWOX expression is deficient in EHCC tissues compared to healthy controls. To investigate the relevance of WWOX to EHCC tumorigenesis and explore the underlying mechanism, we searched for possible WWOX-interacting proteins using PepCyber, Uniprot, DOMINO, ELM, PDZbase and the 3DID database. WWOX functions primarily through binding to the P-P-X-Y motif of target proteins via its WW domain, and it acts as a tumor suppressor by modulating the function of target proteins. We indentified P38, an important MAPK involved in EHCC, as one of several P-P-X-Y motif-containing proteins. To investigate the putative interaction between WWOX and P38, we employed wild and mutant types of P38 and WWOX plasmids in our experiments [details of mutation were contained in Materials and Methods]. Co-IP assays were performed using these constructs. As shown in Fig. 1A and B, wt-WWOX interacted with wt-P38, while the binding affinity between wt-WWOX and mt-P38 was much lower. Binding of mt-WWOX and wt-P38 was similar with that of wt-WWOX and mt-P38. Furthermore, binding was completely abolished when both WWOX and P38 were mutated. To verify co-localization of WWOX with P38, we used Confocal Laser Scanning Microscopy [CLSM] . As shown in Fig. 1C , both WWOX [red] and p38 [green] localized in the cytoplasm. When cells were under stress, such as during stimulation with IL-6, P38 and WWOX still co-localized in the cytoplasm. Then we employed a normal bile duct cell lines KNBD to detect the endogenous WWOX-P38 binding. As expected, WWOX and P38 co-localized in the cytoplasm. When KNBD cells were treated with IL-6, no obvious nuclear translocalization of P38 was observed. Together, these experiments confirmed that WWOX co-localized with and therefore interacted with P38 in vivo.
WWOX did not alter the expression and phosphorylation state of P38 MAPK, but it did sequester P38 in cytoplasm
After confirming the interaction between WWOX and P38, We next analyzed the effect of WWOX on P38. As shown in Fig. 2A and B, when WWOX was introduced into QBC939 cells, neither expression nor the phosphorylation state of P38 were noticeably changed. Similarly, when the WW1 domain of WWOX was mutated, neither the expression nor the phosphorylation state of P38 was affected. We next investigated the effect of WWOX on P38 under stress conditions. As shown in Fig. 2C and D, phosphorylation of P38 was significantly elevated in RBE cells following treatment with IL-6. However, phosphorylation and expression of P38 were not changed after WWOX was introduced in the presence of IL-6. A previous report indicated that WWOX modulates the function of transcription factors Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
by sequestering in the cytoplasm through physical interactions. Therefore, we wanted to know whether WWOX modulated the sub-cellular localization of P38. As shown in Fig.  2E , endogenous P38 localized to the cytoplasm and nuclei of HuCCA-1 cells, suggesting an activated P38. When WWOX was over-expressed, however, the nuclear distribution of P38 decreased and P38 co-localized with WWOX in the cytoplasm, We found similar results in HEK293 cells (Fig. 1C) . Additionally, IL-6-induced nuclear accumulation of P38 decreased when WWOX was introduced into HEK293 cells. To further confirm the effect of WWOX on p38 subcellular localization, we extracted the subcellular fractionation of HuCCA-1 cells and performed Western blotting. As shown in Fig. 2F and G.WWOX introduction caused dramatic decrease in nuclear distribution of P38. These data indicated that WWOX did not affect P38 expression and phosphorylation, but rather specifically inhibited the nuclear accumulation of P38.
WWOX inhibited the phosphorylation of ATF-2 and eIF-4E in a P38 MAPK-dependent manner
Activated P38 translocates to the nucleus, where it phosphorylates downstream transcriptional factors. ATF2 and eIF-4E are known P38 substrates that play important roles in tumorigenesis. Therefore, we tested the effect of WWOX on the phosphorylation HEK293 cells were transfected with P38 plasmid or P38 plasmid plus WWOX plasmid, and 24 h later, the cells were treated with IL-6 or left untreated for an additional 6 h, followed by processing for immunofluorescence.
[D] KNBD cells were treated with IL-6 or left untreated for 6 h, followed by processing for immunofluorescence. Bar=10 μm.
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Cellular Physiology and Biochemistry of these two molecules. As shown in Fig. 3A -C, over-expression of WWOX led to decreased levels of phosphorylated ATF2 and eIF-4E, an effect that was lost in the presence of mutant WWOX. Because mutated WWOX displayed impaired binding to P38, we performed rescue experiments to test the involvement of P38 in WWOX-induced down-regulation of ATF2 and eIF-4E phosphorylation. As shown in Fig. 3D and E, after introduction of P38, the reduction in ATF2 phosphorylation was restored to the level of WWOX-deficient cells. Phosphorylation of eIF-4E showed a similar trend after P38 was introduced ( Fig. 3D and F) . These results demonstrated that WWOX inhibited the phosphoylation of ATF2 and eIF-4E through P38 binding.
WWOX suppressed cell proliferation while inducing cell apoptosis via P38 MAPK
WWOX functions as a tumor suppressor, but there are no reports regarding its role in cholangiocarcinomas, particularly extrahepatic cholangiocarcinoma. In a previous study, we have demonstrated the decreased expression of WWOX in EHCC, but its specific role in EHCC was not defined. Therefore, here we examined the effect of WWOX on cell proliferation and apoptosis in EHCC. As shown in Fig. 4A , the cellular capacity for division was dramatically impaired after infected by WWOX adenovirus. As expected, this phenotype was partially rescued when both WWOX and P38 were over-expressed. A colony formation assay further confirmed the results obtained from the MTT assay (Fig. 4B ). Based on our annexin V-FITC apoptosis assaym, over-expression of WWOX led to increased cell apoptosis, while P38 overexpression significantly decreased the apoptotic ratio (Fig. 4C) . Additionally, the expression levels of the pro-apoptotic proteins Bax and Caspase-3 were greatly increased after overexpression of WWOX. When P38 was introduced simultaneously with WWOX, the expression levels of Bax and Caspase-3 were elevated to a lesser extent than when the cells were in the presence of WWOX alone ( Fig. 4D and E) . Bcl-2, an anti-apoptotic protein, displayed the opposite expression pattern when the WWOX or P38 plasmids were introduced into QBC939 cells ( Fig. 4D and E) . These data demonstrated that WWOX suppressed cell proliferation and induced apoptosis in a P38 MAPK-dependent manner.
WWOX expression was negatively associated with phosphorylated ATF2 in EHCC tissues
Given that the phosphorylation of ATF2 and eIF-4E was down-regulated by WWOX, we next sought to detect phosphorylated ATF2 and eIF-4E in EHCC samples, and measured whether there was a clinical correlation between WWOX and ATF2 or eIF-4E in human tissue samples. We performed immunohistochemical analysis to assess the expression levels of WWOX, P38, and p-ATF2 or p-eIF-4E in 5 human normal bile duct samples and 30 EHCC samples. As shown in Fig. 5A , normal biliary duct tissue exhibited no positive staining for p-ATF2, but it did showe positive staining for WWOX. In contrast, the expression levels of p-ATF2 in EHCC samples were up-regulated compared to normal controls, whereas WWOX expression was lost in EHCC. P38 staining was positive in both normal and EHCC tissues. But more P38 localized in nucleus in EHCC compared with normal controls. The average foldchange of WWOX expression in EHCC was significantly lower than in normal bile duct samples (Fig. 5B) , while that of nuclear P38 level and p-ATF2 expression in EHCC was significantly Fig. 5C and D) . Furthermore, an association study showed that nuclear P38 level and p-ATF2 expression negatively correlated with WWOX expression in these tissue samples ( Fig. 5E and F) . These in vivo findings are consistent with previous in vitro observations that WWOX inhibits nuclear-localization of P38 as well as the phosphorylation of ATF2.
Discussion
EHCC is the second most common primary hepatic malignancy worldwide. Due to the poor prognosis, the majority of EHCC patients die within one year. Therefore, exploring the pathogenesis of EHCC, and finding effective markers for diagnosis and prognosis, as well as novel therapeutic target, is of great value for the treatment of EHCC.
Here, we demonstrated that WWOX interacted with P38 MAPK and prevented it from translocating to the nucleus and activating the transcriptional factors ATF2 and eIF-4E. WWOX suppressed EHCC cell proliferation and inducing apoptosis in a P38 MAPK-dependent manner. In EHCC samples, we found that the expression of WWOX was significantly lower relative to RBE cells were mocktreated or transfected with WWOX plasmid or WWOX plasmid plus P38 plasmid, and 48 h later, the Annexin V-FITC apoptosis assay was performed.
[D] QBC939 cells were mock-treated or transfected with WWOX plasmid or WWOX plasmid plus P38 plasmid, followed by detection of apoptosis-associated protein 24 h later.
[E] Quantification of protein expression. *, p value is less than 0.05 vs. control.
normal control tissues, and it was negatively correlated with the level of phosphorylated ATF2. These results suggested that the WWOX-pATF2 correlation may have prognostic value. The WWOX-p38-ATF2 pathway elucidated in this study is likely an important component of the underlying mechanisms of EHCC tumorigenesis and progression. To our knowledge, this is the first study reporting the role of WWOX in EHCC. Targeting strategies based on the newly discovered WWOX-p38-ATF2 pathway may be exploited in the near future.
WWOX contains two WW domains in its N-terminal region. The first associates with the P-P-X-Y motif of a number of transcription factors, leading to the suppression of transcriptional activities by sequestering these proteins in the cytoplasm. Therefore, the role of WWOX in various signal transduction pathways is indirect. Until now, there have been no reports that defined P38 MAPK as a WWOX interacting partner. Our results here revealed that P38 is a WWOX-associated protein, expanding the current understanding of WWOXmediated signaling. In addition to the N-terminal WW domains, the C-terminus of WWOX contains a short-chain alcohol dehydrogenase reductase SDR] domain, which is involved in regulation of metabolic steroids activities. We did not involve the SDR domain in our study because EHCC is not hormone-dependent.
The stability and sub-cellular localization of WWOX are regulated by its phosphorylation. Tyr33 and Tyr287 are the known phosphorylation sites of WWOX. Tyr33 phosphorylation can induce the nuclear translocation of WWOX and inhibit its ability to bind to interacting partners. In contrast, Tyr287 phosphorylation is associated with poly-ubiquitination and degradation. However, the interaction between WWOX and P38 did not affect the P38 MAPK has been implicated in the tumorigenesis of EHCC. The P38 signaling pathway is a notable molecular feature of this cancer, and utilizing therapeutic targets and inhibitors of P38 MAPK, such as SB203580, will undoubtedly be key strategies for EHCC treatment [31] . Importantly, our study elucidated a novel and effective mechanism to modulate the activity of P38. That is, altering the sub-cellular localization of P38 by introducing WWOX, with the goal of attenuating its phosphorylation of transcriptional factors in the nucleus. In addition, although the phosphorylation and activation of P38 are both necessary for its nuclear translocation, WWOX did not regulate the phosphorylation of P38, but rather only sequestered it in the cytoplasm. It has been reported that P38 has at least 4 isoforms. In this study, all of the analyses were performed with P38 alpha. In addition to the alpha isoform, beta, gamma, and delta isoforms of P38 also exist. We analyzed the sequence of other isoforms of P38, and did not find PPXY motif in them. Theoretically, WWOX specifically binds alpha P38. ATF2 is expressed ubiquitously and can form either homodimers or heterodimers with c-Fos, Fra2 and c-Jun to transcriptionally activate target gene expression by binding to CRE [cAMP response element] consensus sequences or to activator protein 1 [AP-1] consensus sequences. The tumor-promoting role of ATF2 has been implicated in several types of cancer, such as melanoma and skin carcinoma [32] . Here, our data suggested for the first time the involvement of ATF2 in EHCC, as phosphorylation of ATF2 was increased in EHCC samples. This result provides the possibility of exploiting p-ATF2 as a useful prognostic marker. The high level of phosphorylated ATF2 in EHCC was most likely due to the deficiency of WWOX. In addition to regulation by phosphorylation, ATF2 activity can also be regulated by mechanisms such as its sub-cellular localization and the maintenance of stability. Our study did not investigate the effect of WWOX and P38 on sub-cellular localization or stability of ATF2, therefore, further experiments will be needed in the future. ATF7, another member of the activating transcription factor [ATF] family, is structurally similar to ATF2, particularly within the basic region/leucine zipper [bZIP] DNA-binding and dimerization domains. However, we did not find the same results with of ATF7 as with ATF2 in our system, suggesting distinct roles for these proteins EHCC [data not shown]. Further investigation is needed to better understand the differences between these two family members.
Taken together, our data in this study revealed that WWOX interacts with P38 MAPK, leading to the cytoplasmic retention of P38 and inhibition of ATF2 and eIF-4E phosphorylation. Ectopic expression of WWOX reduced proliferation and induced apoptosis in EHCC cells. Additionally, WWOX expression was significantly lower and negatively correlated with phosphorylated ATF2 levels in EHCC tissues, compared to normal samples. To our knowledge, this is the first study reporting the role and underlying mechanism of WWOX in EHCC. Our data not only expand the current understanding of WWOX-mediated signaling, but they also provid the possibility of exploiting WWOX/p-ATF2 as a useful diagnostic and prognostic marker, as well as a novel therapeutic target for the treatment of EHCC.
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